BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1673 related articles for article (PubMed ID: 30324412)

  • 1. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY;
    Osteoporos Int; 2019 Jan; 30(1):3-44. PubMed ID: 30324412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; McCloskey EV; Johansson H; Cooper C; Rizzoli R; Reginster JY;
    Osteoporos Int; 2013 Jan; 24(1):23-57. PubMed ID: 23079689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY;
    Aging Clin Exp Res; 2019 Jan; 31(1):15-17. PubMed ID: 30612282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; Burlet N; Cooper C; Delmas PD; Reginster JY; Borgstrom F; Rizzoli R;
    Osteoporos Int; 2008 Apr; 19(4):399-428. PubMed ID: 18266020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY;
    Calcif Tissue Int; 2019 Mar; 104(3):235-238. PubMed ID: 30796490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
    Kanis JA; Harvey NC; McCloskey E; Bruyère O; Veronese N; Lorentzon M; Cooper C; Rizzoli R; Adib G; Al-Daghri N; Campusano C; Chandran M; Dawson-Hughes B; Javaid K; Jiwa F; Johansson H; Lee JK; Liu E; Messina D; Mkinsi O; Pinto D; Prieto-Alhambra D; Saag K; Xia W; Zakraoui L; Reginster J-
    Osteoporos Int; 2020 Jan; 31(1):1-12. PubMed ID: 31720707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging.
    Shevroja E; Reginster JY; Lamy O; Al-Daghri N; Chandran M; Demoux-Baiada AL; Kohlmeier L; Lecart MP; Messina D; Camargos BM; Payer J; Tuzun S; Veronese N; Cooper C; McCloskey EV; Harvey NC
    Osteoporos Int; 2023 Sep; 34(9):1501-1529. PubMed ID: 37393412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.
    Cheung E; Cheung CL; Kung AW; Tan KC
    Osteoporos Int; 2014 Mar; 25(3):1017-23. PubMed ID: 24196720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2018 update of French recommendations on the management of postmenopausal osteoporosis.
    Briot K; Roux C; Thomas T; Blain H; Buchon D; Chapurlat R; Debiais F; Feron JM; Gauvain JB; Guggenbuhl P; Legrand E; Lehr-Drylewicz AM; Lespessailles E; Tremollieres F; Weryha G; Cortet B
    Joint Bone Spine; 2018 Oct; 85(5):519-530. PubMed ID: 29654947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.
    Cheung EY; Bow CH; Cheung CL; Soong C; Yeung S; Loong C; Kung A
    Osteoporos Int; 2012 Mar; 23(3):871-8. PubMed ID: 21562875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD; Martineau P; Bryanton M; Lix LM
    Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for fracture risk assessment and management of osteoporosis in postmenopausal women and men above the age of 50 in Qatar.
    Alam F; Alsaed O; Abdulla N; Abdulmomen I; Lutf A; Al Emadi S
    Arch Osteoporos; 2024 May; 19(1):34. PubMed ID: 38698101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive undertreatment of osteoporosis in older Swedish women.
    Lorentzon M; Nilsson AG; Johansson H; Kanis JA; Mellström D; Sundh D
    Osteoporos Int; 2019 Jun; 30(6):1297-1305. PubMed ID: 30805678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
    Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
    Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goal-directed treatment of osteoporosis in Europe.
    Kanis JA; McCloskey E; Branco J; Brandi ML; Dennison E; Devogelaer JP; Ferrari S; Kaufman JM; Papapoulos S; Reginster JY; Rizzoli R
    Osteoporos Int; 2014 Nov; 25(11):2533-43. PubMed ID: 25199574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
    Roux C; Cooper C; Díez-Pérez A; Martinez L; Ortolani S; Gitlin M; Möller G; Shepherd S; Freemantle N
    Osteoporos Int; 2011 Apr; 22(4):1227-36. PubMed ID: 20628731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
    McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
    Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
    Siris ES; Adler R; Bilezikian J; Bolognese M; Dawson-Hughes B; Favus MJ; Harris ST; Jan de Beur SM; Khosla S; Lane NE; Lindsay R; Nana AD; Orwoll ES; Saag K; Silverman S; Watts NB
    Osteoporos Int; 2014 May; 25(5):1439-43. PubMed ID: 24577348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.